LungLife AI, INC Block Listing Six Monthly Return (0177G)

TIDMLLAI

RNS Number : 0177G

LungLife AI, INC

15 November 2022

LungLife AI, Inc.

("LungLife" or the "Company")

Block Listing Six Monthly Return

LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, makes the following six-monthly update on its block listing:

 
 Name of applicant:                      LungLife AI, Inc. 
 Name of scheme:                              1. 2010 Stock Incentive Plan 
                                               2. 2020 Stock Incentive Plan 
                                               3. 2021 Omnibus Long-Term Incentive 
                                               Plan 
                                        ---------------------------------------------- 
 Number and class of securities          1,356,139 common shares of US 
  originally admitted:                    $0.0001 each 
                                        ---------------------------------------------- 
 Date of admission:                      15 November 2021 
                                        ---------------------------------------------- 
 Period of return:              From:    15 May 2022        To:    15 November 
                                                                    2022 
                               -------  -----------------  -----  -------------------- 
 Balance of unallotted securities             1. 480,775 
  under scheme(s) from previous 
  return: 
                                               2. 201,374 
                                               3. 673,990 
                                        ---------------------------------------------- 
 Plus: The amount by which the                1. NIL 
  block scheme(s) has been increased           2. NIL 
  since the date of the last                   3. NIL 
  return (if any increase has 
  been applied for): 
                                        ---------------------------------------------- 
 Less: Number of securities                   1. 5,192 
  issued/allotted under scheme(s) 
  during period (see LR3.5.7G): 
                                               2. NIL 
                                               3. NIL 
                                        ---------------------------------------------- 
 Equals: Balance under scheme(s)              1. 475,583 
  not yet issued/allotted at 
  end of period: 
                                               2. 201,374 
                                               3. 673,990 
                                        ---------------------------------------------- 
 
 
 
 Name of contact:               David Anderson, Chief Financial 
                                 Officer 
 Telephone number of contact:   + 44 (0)20 7933 8780 or lunglifeai@walbrookpr.com 
                               --------------------------------------------------

For further information please contact:

 
LungLife AI, Inc.                                                   www.lunglifeai.com 
Paul Pagano, CEO                                                       Via Walbrook PR 
David Anderson, CFO 
 
Investec Bank plc (Nominated                                  Tel: +44 (0)20 7597 5970 
 Adviser & Broker) 
Daniel Adams / Virginia Bull / 
 Cameron MacRitchie 
 
Walbrook PR Limited              Tel: +44 (0)20 7933 8780 or LungLifeAI@walbrookpr.com 
Paul McManus / Alice Woodings                     Mob: 07980 541 893 / 07407 804 654 / 
 / Phil Marriage                                                     +44 07867 984 082

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRGPGUUGUPPGPU

(END) Dow Jones Newswires

November 15, 2022 02:00 ET (07:00 GMT)

Lunglife Ai (LSE:LLAI)
Historical Stock Chart
From May 2024 to Jun 2024